Drugs / ClinOleic
Trials 10 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT04051840 | Jul 2017 → Jun 2019 | — | The First Affiliated Hospital with Nanjing Medical University | Unknown | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT01096771 | Jun 2010 → Nov 2012 | acute respiratory distress syndrome | Methodist Research Institute, Indianapolis | Terminated | No outcome recorded |
| Phase 2/32 trials | ||||||
| Phase 2/3 | NCT00989339 | Nov 2009 → Dec 2011 | diabetes mellitus, hypertensive disorder, obesity disorder | Emory University | Withdrawn | No outcome recorded |
| Phase 2/3 | NCT00672854 | Nov 2008 → Dec 2010 | — | Emory University | Completed | No outcome recorded |
| Phase 46 trials | ||||||
| Phase 4 | NCT03693287 | Jul 2021 → Aug 2023 | pulmonary immaturity | Ospedali Riuniti Ancona | Unknown | No outcome recorded |
| Phase 4 | NCT04347902 | Jan 2016 → Mar 2020 | intestinal failure–associated liver disease, liver failure | Stanley Dudrick's Memorial Hospital | Completed | No outcome recorded |
| Phase 4 | NCT01943409 | Jul 2013 → Dec 2019 | cancer, ileus, protein-energy malnutrition | Johane Allard | Completed | No outcome recorded |
| Phase 4 | NCT01786759 | Oct 2012 → May 2013 | pulmonary immaturity | Shanghai Jiao Tong University School of Medicine | Unknown | No outcome recorded |
| Phase 4 | NCT01683162 | Jul → Dec 2012 | pulmonary immaturity | Wei Cai | Unknown | No outcome recorded |
| Phase 4 | NCT03149653 | Jan 2012 → Jan 2016 | — | General University Hospital, Prague | Completed | No outcome recorded |
Also used as a comparator or background therapy in 2 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT02185729 Comparator | Jun 2008 → Mar 2012 | metabolic disease | Emory University | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT02760472 Comparator | Mar 2013 → Sep 2015 | retinopathy of prematurity | Carola Pfeiffer-Mosesson | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 12 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ClinOleic | “The next morning, after an overnight fast, they will receive, in random order, Intralipid 20%, ClinOleic 20% or normal saline at 20 ml/hr for 24 hr.” NCT00989339 ↗11“Intravenous glucose will be "dextrose 50%", amino acids (AA) will be "Primene®" and lipids (FAT) will be "Clinoleic®".” NCT03693287 ↗ “Parenteral nutrition with Olive oil/LCT 80:20 (ClinOleic, Baxter Healthcare, USA, OO group)” NCT04347902 ↗ |
| Modality | Other / unclassified | “omega-9 "olive-oil" and omega-6 "soybean oil" based lipid emulsions” NCT01096771 ↗ |
| Route | Intravenous | “ClinOleic 20% Intravenous Emulsion” NCT00672854 ↗ |